Expression Analysis of MIST1 and EMT Markers in Primary Tumor Samples Points to MIST1 as a Biomarker of Cervical Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer. 2013;49(15):3262–3273. doi:10.1016/j.ejca.2013.04.024
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade P, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Morris J, Wang S, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer. 2010;10(10):683–695. doi:10.1038/nrc2899
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Mino-Kenudson M, Liss A, et al. Loss of Trefoil Factor 2 from pancreatic duct glands promotes formation of intraductal papillary mucinous neoplasms in mice. Gastroenterology. 2016;151(6):1232–44.e10. doi:10.1053/j.gastro.2016.07.045
   PubMed Web of Science ®Google Scholar
• Riera K, Jang B, Min J, et al. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa. J Pathol. 2020;251(3):336–347. doi:10.1002/path.5469
   PubMed Web of Science ®Google Scholar
• Alison M. The cellular origins of cancer with particular reference to the gastrointestinal tract. Int J Exp Pathol. 2020;101:132–151. doi:10.1111/iep.12364
   PubMed Web of Science ®Google Scholar
• Hsieh M, Jeng Y, Lee Y. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland. Virchows Archiv Int J Pathol. 2019;475(5):617–624. doi:10.1007/s00428-019-02600-1
   PubMed Web of Science ®Google Scholar
• Chandrashekar D, Bashel B, Balasubramanya S, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, NY). 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Bai M, Che Y, Lu K, Fu L. Analysis of deubiquitinase OTUD5 as a biomarker and therapeutic target for cervical cancer by bioinformatic analysis. PeerJ. 2020;8:e9146. doi:10.7717/peerj.9146
   PubMed Web of Science ®Google Scholar
• Warde-Farley D, Donaldson S, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214–20. doi:10.1093/nar/gkq537
   PubMed Web of Science ®Google Scholar
• Mejía L, Muñoz D, Trueba G, Tinoco L, Zapata S. Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women. J Med Virol. 2016;88(1):144–152. doi:10.1002/jmv.24310
   PubMed Web of Science ®Google Scholar
• Kori M, Yalcin Arga K. Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective. PLoS One. 2018;13(7):e0200717. doi:10.1371/journal.pone.0200717
   PubMed Web of Science ®Google Scholar
• Litjens R, Hopman A, van de Vijver K, Ramaekers F, Kruitwagen R, Kruse A. Molecular biomarkers in cervical cancer diagnosis: a critical appraisal. Expert Opin Med Diagn. 2013;7(4):365–377. doi:10.1517/17530059.2013.808621
   PubMedGoogle Scholar
• Nienhüser H, Kim W, Malagola E, et al. Mist1+ gastric isthmus stem cells are regulated by Wnt5a and expand in response to injury and inflammation in mice. Gut. 2020;70:654–665. doi:10.1136/gutjnl-2020-320742
   PubMed Web of Science ®Google Scholar
• Yamada S, Yamanoi K, Sato Y, Nakayama J. Diffuse MIST1 expression and decreased α1, 4-linked N-acetylglucosamine (αGlcNAc) glycosylation on MUC6 are distinct hallmarks for gastric neoplasms showing oxyntic gland differentiation. Histopathology. 2020;77(3):413–422. doi:10.1111/his.14165
   PubMed Web of Science ®Google Scholar
• Young C, Baker R, Howlett C, et al. The loss of ATRX increases susceptibility to pancreatic injury and oncogenic KRAS in female but not male mice. Cell Mol Gastroenterol Hepatol. 2019;7(1):93–113. doi:10.1016/j.jcmgh.2018.09.004
   PubMed Web of Science ®Google Scholar
• Brembeck F, Schreiber F, Deramaudt T, et al. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 2003;63(9):2005–2009.
   PubMed Web of Science ®Google Scholar
• Guerra C, Schuhmacher A, Cañamero M, et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell. 2007;11(3):291–302.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wang W, Xie X, Song Y, Dang C, Zhang H. Methylation-induced silencing of SPG20 facilitates gastric cancer cell proliferation by activating the EGFR/MAPK pathway. Biochem Biophys Res Commun. 2018;500(2):411–417. doi:10.1016/j.bbrc.2018.04.089
   PubMed Web of Science ®Google Scholar
• Direnzo D, Hess D, Damsz B, et al. Induced Mist1 expression promotes remodeling of mouse pancreatic acinar cells. Gastroenterology. 2012;143(2):469–480. doi:10.1053/j.gastro.2012.04.011
   PubMed Web of Science ®Google Scholar
• Chung W, Zhou Y, Atfi A, Xu K. Downregulation of notch signaling in Kras-induced gastric metaplasia. Neoplasia (New York, NY). 2019;21(8):810–821. doi:10.1016/j.neo.2019.06.003
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149(6):1192–1205. doi:10.1016/j.cell.2012.05.012
   PubMed Web of Science ®Google Scholar
• Sakai E, Nakayama M, Oshima H, et al. Combined mutation of Apc, Kras, and Tgfbr2 effectively drives metastasis of intestinal cancer. Cancer Res. 2018;78(5):1334–1346. doi:10.1158/0008-5472.CAN-17-3303
   PubMed Web of Science ®Google Scholar
• Nguyen V, Hough R, Bernaudo S, Peng C. Wnt/β-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis. J Ovarian Res. 2019;12(1):122. doi:10.1186/s13048-019-0596-z
   PubMed Web of Science ®Google Scholar